Two studies led by UAB examine minority participation in cancer clinical trials.

The research was conducted as part of a consortium of five institutions called EMPaCT, Enhancing Minority Participation in Clinical Trials.

The first study, led jointly by Raegan Durant, M.D., MPH and Michelle Martin, Ph.D., both assistant professors in UAB’s Division of Preventive Medicine, used 91 interviews of cancer center administrators, principal investigators, research staff and referring clinicians from the five EMPaCT institutions to identify key themes related to barriers and facilitators of minority recruitment.

Read more at: